← Back to Analyst Consensus 
ELTX Buy
Elicio Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 24, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Aug 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 16, 2026 | Jones Trading | downgrade | Buy → Hold | — | 50% |
| Jun 15, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 10, 2026 | B. Riley Securities | initiate | — → Buy | — | 54% |
| May 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 15, 2026 | Ladenburg Thalmann | initiate | — → Buy | — | 45% |
| Mar 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 10, 2026 | Rodman & Renshaw | initiate | — → Buy | — | 40% |
| Jul 17, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| Apr 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 31, 2024 | Jones Trading | initiate | — → Buy | $9 | 50% |
| Aug 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Apr 1, 2024 | Oppenheimer | reiterate | Perform → Perform | $0 | 52% |
| Jan 17, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
Price Target Trend
Apr 22, 2026 Latest: $13.67 Oct 24, 2026
EPS Estimates
0y $-1.89
Lo: $-2.17 Hi: $-1.70
4 analysts +1q $-0.41
Lo: $-0.55 Hi: $-0.30
4 analysts 0q $-0.43
Lo: $-0.48 Hi: $-0.40
4 analysts +1y $-1.69
Lo: $-2.74 Hi: $-1.10
4 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days